Navigation Links
Glaucoma Research Foundation Celebrates National Glaucoma Awareness Month
Date:12/29/2008

SAN FRANCISCO, Dec. 29 /PRNewswire/ -- In celebration of National Glaucoma Awareness Month, Glaucoma Research Foundation (GRF) will commemorate its 31st Anniversary with a benefit at the historic Palace Hotel in San Francisco, Jan. 28, 2009. The annual event serves as the showcase for recent advances in GRF-funded research.

Glaucoma is the leading cause of preventable blindness. With an aging population, millions worldwide risk blindness from glaucoma if nothing is done. "Early detection and treatment is the only way to prevent further vision loss," says Thomas M. Brunner, GRF president and CEO. "At GRF, we believe that a cure is attainable in the future and National Glaucoma Awareness Month helps us raise awareness for potential treatments and cures available to glaucoma patients today."

The Benefit begins at 5 p.m. with a scientific overview of recent research advances presented by the four principal investigators of GRF's Catalyst for a Cure (CFC) consortium. A reception follows at 6 p.m. and dinner commences at 7 p.m.

Individual Benefit tickets are $300, with tables available at $25,000, $15,000, $10,000 and $6,000. For information or to receive an invitation, please contact Craig Palmer, 415.986.3162 or cpalmer@glaucoma.org.

About the Glaucoma Research Foundation

Glaucoma is the leading cause of preventable blindness. Founded in 1978 in San Francisco, the Glaucoma Research Foundation is the oldest national foundation dedicated to preventing vision loss from glaucoma by investing in innovative research, education and support with the ultimate goal of finding a cure.

http://www.glaucoma.org


'/>"/>
SOURCE Glaucoma Research Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Glaucoma surgery in the blink of an eye
3. Glaucoma surgery in the blink of an eye
4. Chair of U.S. Preventive Services Task Force Pledges to Recommend Re-evaluation of Recent Glaucoma Findings
5. Looking at Glaucoma as a Systemic Disease
6. Cost of glaucoma medications may impact treatment
7. January is National Glaucoma Awareness Month
8. Upcoming meeting will explore new technologies for glaucoma clinical drug trials
9. Dr. Welsh Self-Test Diagnoses Glaucoma, the Leading Cause of Preventable- Blindness
10. Mayor Bloomberg Declares March 6, 2008 World Glaucoma Day in New York City
11. Glaucoma May Boost Cardiovascular Death Risk in Blacks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... ... enables researchers to pursue the recent RNA methylation “gold rush” with their established ... of the newfound characteristics of N6-methyladenosine, or m6A , RNA methylation has ...
(Date:3/27/2017)... ... March 27, 2017 , ... The Association of Healthcare ... will hold their first Northeast Regional AHVAP Meeting. For 2017, Dr. Hayes will ... chain and value analysis professionals have a ‘seat at the table’ with clinical ...
(Date:3/27/2017)... ... ... According to the American Cancer Society , the average 15-year survival ... the cancer spreads to other organs, bones, or lymph nodes, however, the 5-year survival ... latter group, tune in to Lifestyle Magazine on April 9, 2017, to ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... sodium testing methods are complicated and require expert user knowledge. In a live ... method dedicated to the simplified, yet highly accurate, determination of sodium. , It ...
(Date:3/27/2017)... ... 27, 2017 , ... ?Grow Healthy Vending LLC announced today ... between itself and 1800 Vending DBA Healthy You Vending. (Civil No. 1:14-CV-00121-CW/ United ... announce that we have now reached a settlement agreement regarding the ongoing lawsuits ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... March 27, 2017 On Friday, ... NASDAQ Composite closed the trading session up 0.19%; the ... S&P 500 was down 0.08%. US markets made broad ... the day in green. Pre-market today, Stock-Callers.com reviews these ... N.V. (NASDAQ: WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx Group ...
(Date:3/27/2017)... March 27, 2017  Twist Bioscience, a company accelerating ... announced that it raised an additional $33 million. To ... million. "It is an exciting time ... reach and continue to deliver industry-leading gene volume to ... commented Emily M. Leproust, Ph.D., CEO of Twist Bioscience. ...
(Date:3/27/2017)... , March 27, 2017  PhaseRx, Inc. ... for life-threatening inherited liver diseases in children, today ... full year ended December 31, 2016 and provided ... "PhaseRx continued to make progress during the ... positive results from our non-human primate safety study, and ...
Breaking Medicine Technology: